drugset / Trial / NCT01586052
Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1
NaSingle-groupOpen-labelTreatment
Summary
This purpose of this phase 1 study is to investigate the safety and efficacy of erythropoetin for children with cerebral palsy.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 250 iu/kg | Other |